Explore more Johnson & Johnson sites:
In Kenya, around 1.5 million people—including children—contend with visual impairment or blindness. Sight for Kids, Johnson & Johnson Vision’s global eye care partnership, is devoted to changing these stats, one vision screening at a time.
We spoke to a scientist behind a treatment for the disease that was recently FDA-approved for adolescents ages 12 to 18 to learn how it could give them new hope.
More and more, many previously effective medications are no longer able to fight off the germs that are making us sick, leading to millions of deaths each year. For World Antimicrobial Awareness Week, learn what Johnson & Johnson is doing to combat this health threat around the world.
Johnson & Johnson earned the #2 spot on the Access to Medicine Index, an important measurement of the company's longstanding commitment to make lifesaving medicine available and accessible to those who need it most.
Rates of this blood cancer have jumped more than 125% worldwide since the 1990s. But there's reason to have hope: Today, life expectancy has at least doubled in some cases. That's thanks to increased research, new learnings and innovative advances—and Johnson & Johnson is at the forefront of this crucial work.
More than 200 million people worldwide are living with an autoantibody disease, which occurs when the body attacks its own cells, tissues and proteins.
The Johnson & Johnson WiSTEM2D Scholars Award Program winners have big ideas—and an even bigger drive to inspire other women studying science, technology, engineering, math, manufacturing and design to pursue their dreams, too.
-
What You're Talking About
-
Fact
Three. That’s the number of flu strains that the trivalent vaccine given today protects against. Can you guess how long it’s been in use?
Recent Johnson & Johnson Initiatives in the Spotlight
Learn more about the company’s latest groundbreaking programs, game-changing innovations and global partnerships—all aimed at helping change the trajectory of health for humanity.
